Ureteral Stents Market Overview:
Ureteral Stents Market was valued at $304 million in 2016, and is estimated to reach $449 million by 2023, growing at a CAGR of 5.7% from 2017 to 2023. Ureteral stent is a thin tube introduced into the ureter to prevent or treat blockage of the urine flow from the kidney. This procedure is employed to restore urine flow through blocked ureters and retain the normal functions of kidney. These devices are inserted during or after treating kidney stones or tumors and urinary incontinence.
Increase in the incidence of urological diseases caused by colonization of microorganisms or sedentary lifestyle is the major factor that drives the growth of the global ureteral stents market. In addition, rise in number of kidney transplants, surge in geriatric population, and technological advancements in stents composition materials are expected to boost the market growth. However, lack of skilled professionals and adverse effects associated with the use of ureteral stents hinder the market growth. Conversely, advancements in healthcare infrastructure, rise in healthcare investment in developing countries, and development of ureteral stent tracker products are expected to provide numerous opportunities for the market growth.
Ureteral Stents Market Segmentation
Multiloop stents segment grows at the highest rate due to rise in the prevalence of urological disorders, increase in geriatric population, and technological advancements in multiloop stents segment with reduced complications. In addition, high adoption of these stents and adoption of various marketing strategies by key vendors foster its growth.
Ureteral stents market, by product, 2016 (%)
Snapshot of LAMEA Ureteral Stents Market
The major drivers of the LAMEA ureteral stents market include rise in prevalence of urological diseases and rapid growth in geriatric population. In addition, rise in medical tourism in the region, increase in affordability, and rapid urbanization fuel the growth of the market. Moreover, increase in funding by government organizations and various key vendors to improve the healthcare infrastructure in this region boosts the market growth.
One of the major factor driving the ureteral stents market includes rise in geriatric population. According to statistics of the Brazil Pharma NewsData, 2011, it was estimated that the proportion of elderly population has increased from 9.8% in 2000 to 11.7% in 2010 in men and 7.8% in 2000 to 9.8% in 2010 in women. Thus, increase in elderly population is expected to fuel the demand for ureteral stents for treating various urological disorders.
Saudi Arabia Ureteral Stents Market, 20162023 ($million)
The key players profiled in this report include Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Cook Group Incorporated, C. R. Bard, Inc., Coloplast Ltd., Medline Industries, Inc., Allium Medical Solutions Ltd., Pnn Medical A/S, Teleflex Incorporated, and Olympus Corporation.
The other key players in the value chain include GBUK Healthcare Ltd., Red Leaf Medical, Dextronix, Inc., ROCAMED, and Akina, Inc.
- The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
- The report provides information about the current and upcoming trends in the market from 2016 to 2023, which helps to determine the prevailing opportunities.
- Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
- Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.
- Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the global market.
Ureteral Stents Market Key Segments:
- Open End Stents
- Closed End Stents
- Double Pigtail Stents
- Multiloop Stents
- Metal Stents
- Polymer Stents
- Silicone Stents
- Hybrid Stents
- Polyurethane Stents
- Kidney Stones
- Percutaneous Nephrolithotomy
- Kidney Transplantation
- Urinary Incontinence
By End User
- Ambulatory Surgical Centers (ASCs)
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA